Cancer Eil Therapeutics patent details Bcl-2 inhibitors April 9, 2025 Eil Therapeutics Inc. has synthesized new apoptosis regulator Bcl-2 inhibitors reported to be useful for the treatment of cancer.Read More
Cancer Eil Therapeutics divulges new Bcl-2 inhibitors for cancer July 28, 2023 Eil Therapeutics Inc. has synthesized apoptosis regulator Bcl-2 inhibitors reported to be useful for the treatment of cancer.Read More
Cancer New BCL-2 inhibitors identified at Eil Therapeutics Oct. 7, 2022 Eil Therapeutics Inc. has synthesized new apoptosis regulator BCL-2 inhibitors reported to be useful for the treatment of cancer.Read More
